Showing results (291-300 of 909) with videos related to
Sort By:
Pageof 91
The New England Journal of Medicine|December 5, 2008
Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patientsKenneth Jamerson, Michael A Weber, George L Bakris, et al.Nature Medicine|February 3, 2007
Aldosterone impairs vascular reactivity by decreasing glucose-6-phosphate dehydrogenase activityJane A Leopold, Aamir Dam, Bradley A Maron, et al.The New England Journal of Medicine|November 16, 2010
Eplerenone in patients with systolic heart failure and mild symptomsFaiez Zannad, John J V McMurray, Henry Krum, et al.American Heart Journal|April 30, 2013
Current medical management of stable coronary artery disease before and after elective percutaneous coronary interventionAmer K Ardati, Bertram Pitt, Dean E Smith, et al.European Journal of Heart Failure|November 23, 2016
Data and Safety Monitoring Board evaluation and management of a renal adverse event signal in TOPCATMichael R Bristow, Kavita Sharma, Susan F Assmann, et al.Circulation. Heart Failure|October 8, 2009
Effects of the oral direct renin inhibitor aliskiren in patients with symptomatic heart failureJohn J V McMurray, Bertram Pitt, Roberto Latini, et al.The American Journal of Cardiology|August 19, 2015
Using Natriuretic Peptides for Selection of Patients in Acute Heart Failure Clinical TrialsSakima A Smith, Robert J Mentz, Lothar Roessig, et al.Pharmacoeconomics|May 16, 2019
Correction to: Cost-Effectiveness Analysis of Patiromer and Spironolactone Therapy in Heart Failure Patients with HyperkalemiaMark Bounthavong, Javed Butler, Chantal M Dolan, et al.The New England Journal of Medicine|January 7, 2005
C-reactive protein levels and outcomes after statin therapyPaul M Ridker, Christopher P Cannon, David Morrow, et al.Journal of Diabetes and Its Complications|April 28, 2021
NT-proBNP versus routine clinical risk factors as a predictor of cardiovascular events or death in people with dysglycemia - A brief report from the ORIGIN trialMagnus O Wijkman, Brian L Claggett, Marc A Pfeffer, et al.Pageof 91